bioRxiv Science⌕ Search

Biology subjects

Koyyalagunta, D.

Publications and source records attributed to Koyyalagunta, D..

2 recordsLinked to original sources

mRNABench: A curated benchmark for mature mRNA property and function prediction

Messenger RNA (mRNA) is central in gene expression, and its half-life, localization, and translation efficiency drive phenotypic diversity in eukaryotic cells. While supervised learning has widely been used to study the mRNA regulatory code, self-supervised foundation models support a wider range of transfer learning tasks. However, the dearth and homogeneity of standardized benchmarks limit efforts to pinpoint the strengths of various models. Here, we present O_SCPLOWMC_SCPLOWRNABO_SCPLOWENCHC_SCPLOW, a comprehensive benchmarking suite for mature mRNA biology that evaluates the representational quality of mature mRNA embeddings from self-supervised nucleotide foundation models. We curate ten datasets and 59 prediction tasks that broadly capture salient properties of mature mRNA, and assess the performance of 18 families of nucleotide foundation models for a total of 135K experiments. Using these experiments, we study parameter scaling, compositional generalization from learned biological features, and correlations between sequence compressibility and performance. We identify synergies between two self-supervised learning objectives, and pre-train a new Mamba-based model that achieves state-of-the-art performance using 700x fewer parameters. O_SCPLOWMC_SCPLOWRNABO_SCPLOWENCHC_SCPLOW can be found at: https://github.com/morrislab/mRNABench.

genomics↗

Inferring cancer type-specific patterns of metastatic spread

Cancers differ in how they establish metastases. These differences can be studied by reconstructing the metastatic spread of a cancer from sequencing data of multiple tumors. Current methods to do so are limited by computational scalability and rely on technical assumptions that do not reflect current clinical knowledge. Metient overcomes these limitations using gradient-based, multi-objective optimization to generate multiple hypotheses of metastatic spread and rescores these hypotheses using independent data on genetic distance and organotropism. Unlike current methods, Metient can be used with both clinical sequencing data and barcode-based lineage tracing in preclinical models, enhancing its translatability across systems. In a reanalysis of metastasis in 169 patients and 490 tumors, Metient automatically identifies cancer type-specific trends of metastatic dissemination in melanoma, high-risk neuroblastoma, and non-small cell lung cancer. Its reconstructions often align with expert analyses but frequently reveal more plausible migration histories, including those with more metastasis-to-metastasis seeding and higher polyclonal seeding, offering new avenues for targeting metastatic cells. Metients findings challenge existing assumptions about metastatic spread, enhance our understanding of cancer type-specific metastasis, and offer insights that inform future clinical treatment strategies of metastasis.

cancer biology↗